chartexchange

HEPA
HEPION PHARMS INC
stockOTC

EODNov 17, 2026
0.115USD+13.636%(+0.014)32,939
Loading…
Loading…
Healthcare
Biotechnology
HQ
Edison, NJ, USA
Previous Close
$0.10
Beta
0.07
52-Week High
$0.22 2026-10-29
52-Week Low
$0.03 2026-01-30
SMA 50
$0.11
SMA 200
$0.07
Avg. Vol 10D
48,526
Avg. Vol 30D
33,900
Avg. Vol 90D
39,843
Relative Vol
0.97
11.64M
17,749
Mar 18, 2025 · 1-for-50 (reverse)
HEPA Profile

hepion pharmaceuticals, inc., a biopharmaceutical company, focuses on the development of pleiotropic drug therapy for the treatment of chronic liver diseases in the united states. it is involved in developing crv431, a cyclophilin inhibitor that has completed the phase i clinical trials for multiple biochemical pathways involved in the progression of liver diseases; and tenofovir exalidex, a lipid acyclic nucleoside phosphonate that delivers high intracellular concentrations of the active antiviral agent tenofovir diphosphate for the treatment of hepatitis b. the company was formerly known as contravir pharmaceuticals, inc. and changed its name to hepion pharmaceuticals, inc. in july 2019. hepion pharmaceuticals, inc. was incorporated in 2013 and is headquartered in edison, new jersey.

HEPA Performance
PeriodPriceDateChangeBeta
1W0.142026-11-12-17.86%19.495
1M0.102026-10-19+12.63%1.152
3M0.082026-08-19+53.33%1.672
6M0.072026-05-19+60.62%1.197
1Y0.072025-11-19+60.84%0.065
2Y34.702024-11-19-99.67%—
5Y1,320.002021-11-19-99.99%0.408
HEPA Stock Summary

HEPION PHARMS INC (OTC:HEPA) stock price today is $0.12, and today's volume is 32,939. HEPA is up 13.636% today. The 30 day average volume is 33,900. HEPA market cap is $1.26M with 10.93M shares outstanding.